+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Premenstrual Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768168
  • Report
  • 59 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • Besins Healthcare SA
  • Pfizer Inc
  • Syneos Health Inc
  • Umecrine AB
  • MORE
The global clinical trial report- “2019 Premenstrual Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Premenstrual Syndrome. It presents in-depth analysis of Premenstrual Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Premenstrual Syndrome.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Premenstrual Syndrome clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Premenstrual Syndrome

The research work is prepared through extensive and continuous research on Premenstrual Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Premenstrual Syndrome patients are identified
  • The report includes panorama of Premenstrual Syndrome clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Premenstrual Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Bayer AG
  • Besins Healthcare SA
  • Pfizer Inc
  • Syneos Health Inc
  • Umecrine AB
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Premenstrual Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Premenstrual Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Premenstrual Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Premenstrual Syndrome Treatment, 2019

3. Region wise Premenstrual Syndrome Clinical Trials
3.1 Asia Pacific Premenstrual Syndrome Clinical Trials by Country
3.2 Europe Premenstrual Syndrome Clinical Trials by Country
3.3 North America Premenstrual Syndrome Clinical Trials by Country
3.4 Middle East and Africa Premenstrual Syndrome Clinical Trials by Country
3.5 South and Central America Premenstrual Syndrome Clinical Trials by Country

4. Premenstrual Syndrome Clinical Trial Trends
4.1 Start Year wise Premenstrual Syndrome Clinical Trials
4.2 Phase wise Premenstrual Syndrome Clinical Trials
4.3 Trial Status wise Premenstrual Syndrome Clinical Trials
4.4 Trial Type wise Premenstrual Syndrome Clinical Trials

5. Premenstrual Syndrome Average Enrollment Trends
5.1 Average Enrollment in Premenstrual Syndrome Trials by Year
5.2 Average Enrollment in Premenstrual Syndrome Trials by Phase
5.3 Average Enrollment in Premenstrual Syndrome Trials by Status
5.4 Average Enrollment in Premenstrual Syndrome Trials by Type of Trial

6. Companies Participating in Premenstrual Syndrome Clinical Trials
6.1 Premenstrual Syndrome Trials by Sponsor Type
6.2 Premenstrual Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Premenstrual Syndrome Trials- Phase 1
7.2 Premenstrual Syndrome Trials- Phase 2
7.3 Premenstrual Syndrome Trials- Phase 3
7.4 Premenstrual Syndrome Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Premenstrual Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Figure 5: Europe - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Figure 7: North America - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Figure 9: Premenstrual Syndrome Clinical Trials by Phase
Figure 10: Premenstrual Syndrome Clinical Trials by Trial Status
Figure 11: Premenstrual Syndrome Clinical Trials by Type
Figure 12: Premenstrual Syndrome Clinical Trials by Sponsor Type
Figure 13: Premenstrual Syndrome Clinical Trials by Leading Sponsors
Figure 14: Premenstrual Syndrome Average Enrollment by Phase
Figure 15: Premenstrual Syndrome Average Enrollment by Trial Status
Figure 16: Premenstrual Syndrome Average Enrollment by Type
Figure 17: Premenstrual Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Premenstrual Syndrome- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Premenstrual Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Table 5: Europe - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Table 7: North America - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Premenstrual Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Premenstrual Syndrome Average Enrollment by Phase
Table 15: Premenstrual Syndrome Average Enrollment by Trial Status
Table 16: Premenstrual Syndrome Average Enrollment by Type
Table 17: Premenstrual Syndrome- Average Enrolment by Type of Sponsors
Table 18: Premenstrual Syndrome- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Barij Essence Pharmaceutical Company
  • Bayer AG
  • Besins Healthcare SA
  • InVentiv Group Holdings Inc.
  • Pfizer Inc
  • Syneos Health Inc
  • Teva Pharmaceutical Industries Ltd
  • Torrent Pharmaceuticals Ltd
  • Umecrine AB
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768168
Adroll
adroll